Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer.

MLA

Zhu, Xianbing, et al. “Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer.” Cancer Research, vol. 84, no. 8, Apr. 2024, pp. 1333–51. EBSCOhost, https://doi.org/10.1158/0008-5472.CAN-23-1749.

APA

Zhu, X., Fu, Z., Dutchak, K., Arabzadeh, A., Milette, S., Steinberger, J., Morin, G., Monast, A., Pilon, V., Kong, T., Adams, B. N., Prando Munhoz, E., Hosein, H. J. B., Fang, T., Su, J., Xue, Y., Rayes, R., Sangwan, V., Walsh, L. A., … Huang, S. (2024). Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer. Cancer Research, 84(8), 1333–1351. https://doi.org/10.1158/0008-5472.CAN-23-1749

Chicago

Zhu, Xianbing, Zheng Fu, Kendall Dutchak, Azadeh Arabzadeh, Simon Milette, Jutta Steinberger, Geneviève Morin, et al. 2024. “Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer.” Cancer Research 84 (8): 1333–51. doi:10.1158/0008-5472.CAN-23-1749.